Daniel Len Edmonston, MD

Medical Instructor in the Department of Medicine

Member in the Duke Clinical Research Institute

Email address daniel.edmonston@duke.edu

My primary research focus lies at the intersection of kidney and cardiovascular disease including pulmonary hypertension, heart failure, and atherosclerotic disease in patients with chronic kidney disease.

Education and Training

Fellowship, Nephrology, Duke University, 2016 - 2019
Residency, Medicine, New York Presbyterian Hospital, 2013 - 2016
M.D., Mercer University, School of Medicine, 2013

Grants

"HiLo": Pragmatic trial of higher vs. lower serum phosphate targets in patients undergoing hemodialysis

Publications

South, Andrew M., Laurie Tomlinson, Daniel Edmonston, Swapnil Hiremath, and Matthew A. Sparks. “Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.” Nat Rev Nephrol 16, no. 6 (June 2020): 305–7. https://doi.org/10.1038/s41581-020-0279-4.

PMID

32246101

Full Text

Edmonston, Daniel L., Kishan S. Parikh, Sudarshan Rajagopal, Linda K. Shaw, Dennis Abraham, Alexander Grabner, Matthew A. Sparks, and Myles Wolf. “Pulmonary Hypertension Subtypes and Mortality in CKD.” Am J Kidney Dis 75, no. 5 (May 2020): 713–24. https://doi.org/10.1053/j.ajkd.2019.08.027.

PMID

31732231

Full Text

Edmonston, Daniel, and Myles Wolf. “FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.” Nat Rev Nephrol 16, no. 1 (January 2020): 7–19. https://doi.org/10.1038/s41581-019-0189-5.

PMID

31519999

Full Text

Edmonston, Daniel, Daniel Wojdyla, Rupal Mehta, Xuan Cai, Claudia Lora, Debbie Cohen, Raymond R. Townsend, et al. “Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.” Am J Kidney Dis 74, no. 6 (December 2019): 771–81. https://doi.org/10.1053/j.ajkd.2019.05.026.

PMID

31445926

Full Text

Edmonston, Daniel L., Christina M. Wyatt, and Sana M. Al-Khatib. “Atrial fibrillation and kidney disease: stuck outside the CABANA.” Kidney Int 96, no. 5 (November 2019): 1054–55. https://doi.org/10.1016/j.kint.2019.05.023.

PMID

31443996

Full Text

Edmonston, Daniel L., Jingjing Wu, Roland A. Matsouaka, Clyde Yancy, Paul Heidenreich, Ileana L. Piña, Adrian Hernandez, Gregg C. Fonarow, and Adam D. DeVore. “Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients.” Am Heart J 212 (June 2019): 101–12. https://doi.org/10.1016/j.ahj.2019.03.005.

PMID

30978555

Full Text

Hein, Aaron M., Julia J. Scialla, Daniel Edmonston, Lauren B. Cooper, Adam D. DeVore, and Robert J. Mentz. “Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.” Jacc Heart Fail 7, no. 5 (May 2019): 371–82. https://doi.org/10.1016/j.jchf.2019.02.009.

PMID

31047016

Full Text

Edmonston, Daniel, and Myles Wolf. “Good Guys, Bad Guys, Guesses, and Near Misses in Nephrology.” Clin J Am Soc Nephrol 14, no. 1 (January 7, 2019): 7–9. https://doi.org/10.2215/CJN.13801118.

PMID

30559107

Full Text

Edmonston, Daniel, Myles Wolf, and Michael Pencina. “Statins at Dialysis Transition-Supportive but Not Sufficient.” Jama Netw Open 1, no. 6 (October 5, 2018): e182411. https://doi.org/10.1001/jamanetworkopen.2018.2411.

PMID

30646212

Full Text

McHugh, Kelly R., Adam D. DeVore, Robert J. Mentz, Daniel Edmonston, Jennifer B. Green, and Adrian F. Hernandez. “The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes.” Clin Cardiol 41, no. 9 (September 2018): 1259–67. https://doi.org/10.1002/clc.23054.

PMID

30125365

Full Text

Daniel Len Edmonston, MD

Education and Training

Grants

Publications

Pages